References
- Bielack SS, Kempf-Bielack B, Delling G, et al (2002). Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol, 20, 776-90. https://doi.org/10.1200/JCO.20.3.776
-
Blennow K, Ricksten A, Prince J, et al (2000). No association between the
${\alpha}2$ -macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. J Neural Transm, 107, 1065-79. https://doi.org/10.1007/s007020070052 - Boucher P, Gotthardt M (2004). LRP and PDGF signaling: a pathway to atherosclerosis. Trends Cardiovasc Med, 14, 55-60. https://doi.org/10.1016/j.tcm.2003.12.001
- Broadhead ML, Clark J, Myers DE, et al (2011). The molecular pathogenesis of osteosarcoma: a review. Sarcoma, 2011,
- Carracedo A, Ma L, Teruya-Feldstein J, et al (2008). Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest, 118, 3065.
- Charity R, Foukas A, Deshmukh N, Grimer R (2006). Vascular endothelial growth factor expression in osteosarcoma. Clin Orthop Relat Res, 448, 193-8. https://doi.org/10.1097/01.blo.0000205877.05093.c9
- Diao C-Y, Guo HB, Ouyang YR, et al (2013). Screening for metastatic osteosarcoma biomarkers with a DNA microarray. Asian Pac J Cancer Prev, 15, 1817-22.
- Duncan D, Prodduturi N, Zhang B (2010). WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. BMC Bioinformatics, 11, 10. https://doi.org/10.1186/1471-2105-11-10
- Flores RJ, Li Y, Yu A, et al (2012). A systems biology approach reveals common metastatic pathways in osteosarcoma. BMC Syst Biol, 6, 50. https://doi.org/10.1186/1752-0509-6-50
- Fuchs B, Pritchard DJ (2002). Etiology of osteosarcoma. Clin Orthop Relat Res, 397, 40-52. https://doi.org/10.1097/00003086-200204000-00007
- Fujita A, Sato J, Rodrigues L, et al (2006). Evaluating different methods of microarray data normalization. BMC Bioinformatics, 7, 469. https://doi.org/10.1186/1471-2105-7-469
- Fujita T, Nagayama A, Anazawa S (2003). Circulating alpha-2-macroglobulin levels and depression scores in patients who underwent abdominal cancer surgery. J Surg Res, 114, 90-4. https://doi.org/10.1016/S0022-4804(03)00194-X
- He Y, Liang X, Meng C, et al (2014). Genetic polymorphisms of interleukin-1 beta and osteosarcoma risk. Int Orthop, 1-6.
- Herz J, Strickland D K (2001). LRP: a multifunctional scavenger and signaling receptor. J Clin Invest, 108, 779-84. https://doi.org/10.1172/JCI200113992
- Hu J, Feng D, Cheng R (2001). Expressions of p-MAPK, cyclin D1, p53 protein and their relationship in osteosarcoma. Hunan Yi Ke Da Xue Xue Bao, 26, 325.
- Hulka BS, Moorman PG (2008). Reprint of breast cancer: hormones and other risk factors. Maturitas, 61, 203-13. https://doi.org/10.1016/j.maturitas.2008.11.016
- Jia J, Tian Q, Liu Y, et al (2013). Interactive effect of bisphenol A (BPA) exposure with-22G/C polymorphism in LOX gene on the risk of osteosarcoma. Asian Pac J Cancer Prev, 14, 3805-8. https://doi.org/10.7314/APJCP.2013.14.6.3805
- Jiang W G, Ye L, Ji K, et al (2013). Antitumour effects of Yangzheng Xiaoji in human osteosarcoma: The pivotal role of focal adhesion kinase signalling. Oncol Rep, 30, 1405-13.
- Kansara M, Thomas DM (2007). Molecular pathogenesis of osteosarcoma. DNA Cell Biol, 26, 1-18. https://doi.org/10.1089/dna.2006.0505
- Kaste SC, Pratt CB, Cain AM, et al (1999). Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis. Cancer, 86, 1602-8. https://doi.org/10.1002/(SICI)1097-0142(19991015)86:8<1602::AID-CNCR31>3.0.CO;2-R
- Kubista B, Klinglmueller F, Bilban M, et al (2011). Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma. Int Orthop, 35, 401-11. https://doi.org/10.1007/s00264-010-0996-6
- Kubo T, Piperdi S, Rosenblum J, et al (2008). Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma. Cancer, 112, 2119-29. https://doi.org/10.1002/cncr.23437
- Kulmambetova GN, Imanbekova MK, Logvinenko AA, et al (2014). Association of cytokine gene polymorphisms with gastritis in a kazakh population. Asian Pac J Cancer Prev, 15, 7763. https://doi.org/10.7314/APJCP.2014.15.18.7763
- Langlois B, Perrot G, Schneider C, et al (2010). LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways. PLoS One, 5, 11584. https://doi.org/10.1371/journal.pone.0011584
- Lee S-G, Kim B, Choi W, et al (2003). Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B-31 C/+ and IL-1RN* 2/* 2) and gastric cancer/duodenal ulcer in Korean population. Cytokine, 21, 167-71. https://doi.org/10.1016/S1043-4666(03)00032-2
- Li CJ, Cong Y, Liu XZ, et al (2014). Research progress on the livin gene and osteosarcomas. Asian Pac J Cancer Prev, 15, 8577-9. https://doi.org/10.7314/APJCP.2014.15.20.8577
- Lin DS, Cai LY, Ding J, Gao WY (2014). Correlation between E-cadherin-regulated cell adhesion and human osteosarcoma MG-63 cell anoikis. Asian Pac J Cancer Prev, 15, 8203-7. https://doi.org/10.7314/APJCP.2014.15.19.8203
- Linja MJ, Savinainen KJ, Saramaki O R, et al (2001). Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res, 61, 3550-5.
- Link MP, Goorin AM, Miser AW, et al (1986). The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med, 314, 1600. https://doi.org/10.1056/NEJM198606193142502
- Luo Y, Deng Z, Chen J (2013). Pivotal regulatory network and genes in osteosarcoma. Arch Med Sci, 9, 569-75.
- MacMahon B, Cole P, Brown J (1973). Etiology of human breast cancer: a review. J Natl Cancer Inst, 50, 21-42.
- Mialou V, Philip T, Kalifa C, et al (2005). Metastatic osteosarcoma at diagnosis. Cancer, 104, 1100-9. https://doi.org/10.1002/cncr.21263
- Patil A, Nakai K, Nakamura H (2011). HitPredict: a database of quality assessed protein-protein interactions in nine species. Nucleic Acids Res, 39, 744-9. https://doi.org/10.1093/nar/gkq834
- Patil A, Nakamura H (2005). Filtering high-throughput protein-protein interaction data using a combination of genomic features. BMC Bioinformatics, 6, 100. https://doi.org/10.1186/1471-2105-6-100
- Pezzi CM, Pollock RE, Evans HL, et al (1990). Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surge, 211, 476. https://doi.org/10.1097/00000658-199004000-00015
- Pignochino Y, Dell'Aglio C, Basirico M, et al (2013). The combination of sorafenib and everolimus abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models. Clin Cancer Res, 19, 2117-31. https://doi.org/10.1158/1078-0432.CCR-12-2293
- Rehman A A, Ahsan H, Khan F H (2013). alpha-2-Macroglobulin: a physiological guardian. J Cell Physiol, 228, 1665-75. https://doi.org/10.1002/jcp.24266
- Smida J, Baumhoer D, Rosemann M, et al (2010). Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma. Clin Cancer Res, 16, 4256-67. https://doi.org/10.1158/1078-0432.CCR-10-0284
- Smyth G K (2005). Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor. Springer.
- Ta HT, Dass CR, Choong PF, Dunstan DE (2009). Osteosarcoma treatment: state of the art. Cancer Metastasis Rev, 28, 247-63. https://doi.org/10.1007/s10555-009-9186-7
- Takagi S, Takemoto A, Takami M, et al (2014). Platelets promote osteosarcoma cell growth through activation of the platelet-derived growth factor receptor-Akt signaling axis. Cancer Sci, 105, 983-8. https://doi.org/10.1111/cas.12464
- Tingting R, Wei G, Changliang P, et al (2010). Arsenic trioxide inhibits osteosarcoma cell invasiveness via MAPK signaling pathway. Cancer Biology Therapy, 10, 251-7. https://doi.org/10.4161/cbt.10.3.12349
- Trougakos IP, Chondrogianni N, Amarantos I, et al (2010). Genome-wide transcriptome profile of the human osteosarcoma Sa OS and U-2 OS cell lines. Cancer Genet Cytogenet, 196, 109-18. https://doi.org/10.1016/j.cancergencyto.2009.09.012
- Troyanskaya O, Cantor M, Sherlock G, et al (2001). Missing value estimation methods for DNA microarrays. Bioinformatics, 17, 520-5. https://doi.org/10.1093/bioinformatics/17.6.520
- Wang J, Zu J, Xu G, et al (2014). Inhibition of focal adhesion kinase induces apoptosis in human osteosarcoma SAOS-2 cells. Tumor Biol, 35, 1551-6. https://doi.org/10.1007/s13277-013-1214-0
- Yang R, Piperdi S, Gorlick R (2008). Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Clin Cancer Res, 14, 6396-404. https://doi.org/10.1158/1078-0432.CCR-07-5113
- Ye J, Fang L, Zheng H, et al (2006). WEGO: a web tool for plotting GO annotations. Nucleic Acids Res, 34, 293-7. https://doi.org/10.1093/nar/gkl031
- Zhang B, Kirov S, Snoddy J (2005). WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res, 33, 741-8. https://doi.org/10.1093/nar/gki475
Cited by
- Pericytes in sarcomas of bone vol.32, pp.7, 2015, https://doi.org/10.1007/s12032-015-0651-6